… population pharmacokinetic parameters of gentamicin in a large group of premature neonates
… clinical and physiopathological covariates on the pharmacokinetic profile of the drug. …

… gentamicin therapy for premature newborns hospitalized in our neonatal intensive care unit.
… we calculated pharmacokinetic parameters in a population of 43 premature newborns using …

… The purpose of this study was to characterize the population PK parameters of gentamicin
in a large cohort of preterm and term neonates and to investigate the influence of clinical, …

… The population pharmacokinetic parameters of flucloxacillin in the present study differ from
the population pharmacokinetic parameters found by Herngren et al. CL/W (0.04 L kg −1 h −1 …

… Selection of the first dose for neonates in clinical trials is very challenging. … if a population
pharmacokinetic (PK) model developed with data from infants to adults is predictive of neonatal …

… This study was performed to characterize the population pharmacokinetics of gentamicin
in preterm and term neonates and to identify and quantify relationships between patient …

… a few preterm neonates. Thus, we aimed to evaluate the population pharmacokinetics of …
size covering the entire age range of neonates and young infants and to establish evidence-…

… : Population pharmacokinetic modelling in the preterm infant … of pharmacokinetic studies in
neonatal clinical pharmacology. … on the pharmacokinetics of milrinone in very preterm infants. …

… to develop a population pharmacokinetic (PK) model in … preterm neonates. By using an
optimal design approach, a prospective PK study was designed and implemented in 60 neonates …

… developed a population pharmacokinetic model for midazolam in preterm neonates with a
… was it possible to develop a population pharmacokinetic model of this drug. Although the …